Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Squamous cell carcinoma is the second most common type of skin cancer, and can be deadly if left untreated. Here are the ...

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...

When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...

The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...

In a clinical practice guideline issued by the American Society for Radiation Oncology and published online Feb. 27 in ...

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...